THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Mass. biotech firms urged to remain independent

Ted Torphy, chief scientific officer at Johnson & Johnson, was the moderator at the MassBio Investors Forum at the Sheraton Boston. Ted Torphy, chief scientific officer at Johnson & Johnson, was the moderator at the MassBio Investors Forum at the Sheraton Boston. (Pat Greenhouse/ Globe Staff)
By Robert Weisman
Globe Staff / October 7, 2009

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

It’s time for pulling up the bootstraps. That was the message delivered to biotechnology start-ups at the 11th annual MassBio Investors Forum yesterday. At a time when major drug makers are consolidating and may be less willing to buy fledgling companies, biotechs have to make it on their own and bring drugs to market themselves. (Full article: 617 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass